BS29 Expression of stable SOCS3 in human saphenous vein smooth muscle cells: potential therapy for vascular restenosis

Abstract

ConclusionWe successfully upscaled hiPSC-CM derived EHT to a clinically relevant size and were able to demonstrate feasibility and integration using a rabbit model of myocardial infarction. Tissue engineering strategies may be the preferred modality of cell delivery for future cardiac regenerative medicine studies.